854aaaf119221d11ff3f4899aec9bfa4 *DESCRIPTION
0fefb5fef6dd23c0ef1f4c6468c966c9 *NAMESPACE
3396e75c5ac6cf1328e25fb757b0001a *NEWS
68973ff9975b419bfa1f76c94769bbec *R/interim.r
d4d017aaa72e40d318de4fbf3ea4d4ff *man/capacity.Rd
a7186e0cf7f1aa387626e951853a2d83 *man/convertedRate.Rd
bebf5ea496a05518e96bfafcc4a21406 *man/cross.Rd
e3ce2628bbebb26a98a30809e18daab9 *man/interim-package.Rd
1a468db0819adbccd7a00ec9878ea475 *man/recruitment.Rd
2e26eb08acc2d03db63d9d659f90ac3c *man/treatment.Rd
e54715535edc993313c1121d713058e3 *man/trialCourse.Rd
ac9237bd72fe821655b62912a630962f *man/trialWeek.Rd
